Lopinavir Withdrawn Phase 3 Trials for Breastfeeding / Human Immunodeficiency Virus (HIV) Infections / Pregnant State Prevention

Indications	Status	Purpose	Phase
DBCOND0031330 (Breastfeeding) DBCOND0035016 (Human Immunodeficiency Virus (HIV) Infections) DBCOND0056919 (Pregnant State)	Withdrawn	Prevention	3

clinicaltrials.gov Identifier	Title	Drugs
https://clinicaltrials.gov/ct2/show/	Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial	Efavirenz (DB00625) Emtricitabine (DB00879) Lamivudine (DB00709) Lopinavir (DB01601) Ritonavir (DB00503) Tenofovir disoproxil (DB00300) Zidovudine (DB00495)